{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T18:00:09Z","timestamp":1781978409169,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","transplantation-proceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.transproceed.2017.05.007","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T00:49:22Z","timestamp":1505782162000},"page":"1911-1915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Is Cytomegalovirus Surveillance Necessary for Patients With Low Reactivation Risk in an Autologous Hematopoietic Cell Transplantation Setting?"],"prefix":"10.1016","volume":"49","author":[{"given":"A.H.","family":"Kaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Tekgunduz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Akpinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Batgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bekdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Kayikci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Namdaroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.U.","family":"Ulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Dal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.K.","family":"Cakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Korkmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Altuntas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2017.05.007_bib1","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2017.05.007_bib2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.idc.2010.01.008","article-title":"Cytomegalovirus in hematopoietic stem cell transplant recipients","volume":"24","author":"Ljungman","year":"2010","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.transproceed.2017.05.007_bib3","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood.V94.12.4029","article-title":"Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation","volume":"94","author":"Holmberg","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2017.05.007_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/bmt.2008.162","article-title":"Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT","volume":"42","author":"Ljungman","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2017.05.007_bib5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00277-007-0397-0","article-title":"Rituximab therapy increased post-transplant cytomegalovirus complications in non-Hodgkin lymphoma patients receiving autologous hematopoietic stem cell transplantation","volume":"87","author":"Lee","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1016\/j.transproceed.2017.05.007_bib6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/tid.12162","article-title":"High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network","volume":"16","author":"Marchesi","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2017.05.007_bib7","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/tid.12309","article-title":"Evaluation of risk of symptomatic cytomegalovirus reactivation in myeloma patients treated with tandem autologous stem cell transplantation and novel agents: a single-institution study","volume":"16","author":"Marchesi","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2017.05.007_bib8","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.bbmt.2012.06.008","article-title":"Cytomegalovirus reactivation following autologous peripheral blood stem cell transplantation for multiple myeloma in the era of novel chemotherapeutics and tandem transplantation","volume":"18","author":"Kim","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2017.05.007_bib9","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/S0140-6736(00)02350-3","article-title":"Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation","volume":"355","author":"Emery","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2017.05.007_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/bjh.12363","article-title":"Management of cytomegalovirus infection in haemopoietic stem cell transplantation","volume":"162","author":"Emery","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transproceed.2017.05.007_bib11","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/bmt.2013.1","article-title":"Allogeneic matched-sibling hematopoietic cell transplantation for AML: comparable outcomes between Eastern Mediterranean (EMBMT) and European (EBMT) centers","volume":"48","author":"Bazarbachi","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2017.05.007_bib12","first-page":"545","article-title":"Antalya\u2019da Sitomegalovirus seroepidemiyolojisinin toplum kaynakl\u0131 kesitsel bir \u00e7al\u0131\u015fma ile ara\u015ft\u0131r\u0131lmas\u0131 ve T\u00fcrkiye verilerinin derlenmesi","volume":"41","author":"Ataman","year":"2007","journal-title":"Mikrobiyol B\u00fcl"},{"key":"10.1016\/j.transproceed.2017.05.007_bib13","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/339329","article-title":"Definitions of cytomegalovirus infection and disease in transplant recipients","volume":"34","author":"Ljungman","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2017.05.007_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2017.05.007_bib15","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma","volume":"20","author":"Durie","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.transproceed.2017.05.007_bib16","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas: NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.transproceed.2017.05.007_bib17","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1200\/JCO.2005.01.891","article-title":"Response assessment of aggressive non-Hodgkin\u2019s lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography","volume":"23","author":"Juweid","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.transproceed.2017.05.007_bib18","first-page":"94","article-title":"Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation: biology and current indications","volume":"17","author":"Champlin","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/j.transproceed.2017.05.007_bib19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1399-3062.2005.000111.x","article-title":"Cytomegalovirus infection after autologous stem cell transplantation: incidence and outcome in a group of patients undergoing a surveillance program","volume":"7","author":"Rossini","year":"2005","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2017.05.007_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.bmt.1701827","article-title":"Cytomegalovirus viremia, viruria and disease after autologous peripheral blood stem cell transplantation: no need for surveillance","volume":"24","author":"Bilgrami","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2017.05.007_bib21","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1098\/rspb.2006.3506","article-title":"Modelling cytomegalovirus replication patterns in the human host: factors important for pathogenesis","volume":"273","author":"Regoes","year":"2006","journal-title":"Proc Biol Sci"},{"key":"10.1016\/j.transproceed.2017.05.007_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5500\/wjt.v5.i3.129","article-title":"Cytomegalovirus reactivation after autologous stem cell transplantation in myeloma and lymphoma patients: a single-center study","volume":"5","author":"Marchesi","year":"2015","journal-title":"World J Transplant"},{"key":"10.1016\/j.transproceed.2017.05.007_bib23","doi-asserted-by":"crossref","first-page":"e2015049","DOI":"10.4084\/mjhid.2015.049","article-title":"Cytomegalovirus reactivation in adult recipients of autologous stem cell transplantation: a single center experience","volume":"7","author":"Al-Rawi","year":"2015","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.transproceed.2017.05.007_bib24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbmt.2013.10.003","article-title":"Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimen","volume":"20","author":"Manjappa","year":"2014","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134517305250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134517305250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T21:36:50Z","timestamp":1602970610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134517305250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0041134517305250"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2017.05.007","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is Cytomegalovirus Surveillance Necessary for Patients With Low Reactivation Risk in an Autologous Hematopoietic Cell Transplantation Setting?","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2017.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}